A5088113912- Endometriosis Research and Treatment
- Uterine Myomas and Treatments
- Gynecological conditions and treatments
- Intestinal and Peritoneal Adhesions
- Endometrial and Cervical Cancer Treatments
- Ovarian function and disorders
- Reproductive Biology and Fertility
- Pelvic and Acetabular Injuries
- Hypothalamic control of reproductive hormones
- Ovarian cancer diagnosis and treatment
- Pelvic floor disorders treatments
- Reproductive System and Pregnancy
- Hernia repair and management
- Sexual Differentiation and Disorders
- Intraperitoneal and Appendiceal Malignancies
- Pregnancy-related medical research
- Maternal and fetal healthcare
- Colorectal Cancer Surgical Treatments
- Patient Satisfaction in Healthcare
- Ectopic Pregnancy Diagnosis and Management
- Thyroid and Parathyroid Surgery
- Regulation of Appetite and Obesity
- Family Support in Illness
- Ureteral procedures and complications
- Renal cell carcinoma treatment
Ospedale Sacro Cuore Don Calabria
2013-2024
Istituti di Ricovero e Cura a Carattere Scientifico
2019-2024
University of Genoa
2022
Ospedale Policlinico San Martino
2022
Sacred Heart Hospital
2020
University of Naples Federico II
2006-2013
University College Hospital at Westmoreland Street
2012
University College London
2012
The European Academy of Gynaecological Surgery
2011
University of Verona
2010
V-betaLH is a common genetic variant of LH caused by two polymorphic base changes in the beta subunit gene, altering amino acid sequence (Trp8Arg and Ile15Thr). In previous-preliminary trial performed women undergoing IVF, it was demonstrated that carriers v-betaLH show sub-optimal ovarian response to standard long GnRH-agonist down -regulation protocol when stimulated with pure recombinant FSH (r-hFSH). The aim this study confirm hypothesis display hypo-sensitivity exogenous larger IVF...
Background The recurrence of deep infiltrating endometriosis (DIE) after its surgical excision is a big problem: postoperative treatment crucial.Objective To compare two treatments: Dienogest and GnRH agonists.Design Prospective Randomized Controlled Trial (RCT).Patients 146 women submitted to laparoscopic eradication DIE with bowel parametrial surgery.Interventions Patients were randomized into groups. Group A (n = 81) received Triptorelin or Leuprorelin 3.75 mg every 4 weeks for 6 months....